Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Immunol. 2012 Apr 18;13(5):423-7. doi: 10.1038/ni.2264.

Lessons learned from HIV-1 vaccine trials: new priorities and directions.

Author information

  • 1Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. andrew.mcmichael@ndm.ox.ac.uk

Erratum in

  • Nat Immunol. 2013 Apr;14(4):413.

Abstract

A vaccine against human immunodeficiency virus (HIV) seems to be on the horizon. Correlates of risk of infection for [corrected] the RV144 vaccine trial have been found. There is understanding of what makes HIV envelope-specific antibodies broadly neutralizing and new T cell vaccine approaches can overcome virus variability.

PMID:
22513323
[PubMed - indexed for MEDLINE]
PMCID:
PMC3652652
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk